The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation
Keywords: BPAR; biopsy-proven acute rejection; CAV; cardiac allograft vasculopathy; CMV; cytomegalovirus; CNI; calcineurin inhibitor; CsA; cyclosporine; eGFR; estimated glomerular filtration rate; IVUS; intravascular ultrasound; LVAD; left ventricular assist device